Shareholders Equity: The sum of preferred and common equity items.
Mosaic ImmunoEngineering Inc. (CPMV) had Shareholders Equity of $-7.31M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.17M |
|
-- |
|
-- |
|
$0.14M |
|
$-0.14M |
|
$-0.02M |
|
$-0.17M |
|
$-0.17M |
|
$-0.17M |
|
$-0.17M |
|
$-0.17M |
|
$-0.17M |
|
$-0.14M |
|
$-0.14M |
|
7.24M |
|
7.24M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.06M |
|
-- |
|
-- |
|
$0.06M |
|
$5.91M |
|
$1.45M |
|
$1.45M |
|
$7.36M |
|
$-7.31M |
|
$-7.31M |
|
|
Shareholders Equity |
$-7.31M |
7.24M |
|
| Cash Flow Statement Financials | |
$-0.08M |
|
-- |
|
-- |
|
$0.12M |
|
$0.03M |
|
$-0.08M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-0.25 |
|
-0.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2.26% |
|
2.26% |
|
-299.04% |
|
2.82% |
|
$-1.01 |
|
$-0.01 |
|
$-0.01 |
|